Laurie Heilmann Named as Codexis’ SVP of Business Development and Marketing

Codexis appointed Laurie Heilmann as senior vice president of Business Development and Marketing. In her new role she will be responsible for developing the strategies and overseeing the company’s execution to grow global revenues, expand and deepen customer reach, and penetrate a widening set of industrial markets.

Heilmann has more than 30 years of leadership experience across the life sciences industry. Most recently she was president of Global Life Sciences and Diagnostics at Crown Bioscience. Prior to this position, Heilmann served as the company’s chief business officer and as SVP, Global Strategy, Business Development and Marketing. Earlier in her career, she served for 25 years in various sales, management and business development roles at several firms, including Strong-Bridge Consulting, Image Metrix-American College of Radiology, and Ockham Development Group.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.